Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease: The TUXEDO-2 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: February 11, 2026
Ultra-Thin Sirolimus-Eluting Versus Everolimus-Eluting Stents in Diabetic Multivessel Coronary Artery Disease Patients: The TUXEDO-2 Trial.
Journal: Journal of the American College of Cardiology
Published: January 26, 2026
Clinical encounter with three cancer patients affected by groundwater contamination at Camp Lejeune: a case series and review of the literature.
Journal: Journal of medical case reports
Published: May 06, 2022
Reduction in the risk of major adverse cardiovascular events with the BET protein inhibitor apabetalone in patients with recent acute coronary syndrome, type 2 diabetes, and moderate to high likelihood of non-alcoholic fatty liver disease.
Journal: American journal of preventive cardiology
Published: April 18, 2022
Adjuvant and Neoadjuvant Therapeutics for the Treatment of Cutaneous Melanoma.
Journal: Clinics in plastic surgery
Published: September 10, 2021
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.
Journal: Journal of Alzheimer's disease : JAD
Published: August 30, 2021
CD24 Expression May Play a Role as a Predictive Indicator and a Modulator of Cisplatin Treatment Response in Head and Neck Squamous Cellular Carcinoma.
Journal: PloS one
Published: December 17, 2015
Showing 1-7 of 7
Last Updated: 09/26/2026